According to the Zhitong Finance App, Spike Health (00314.HK) announced its 2026 interim results, with total revenue of about 740 million yuan, IFRS net profit of 42.924 million yuan, and profit attributable to parent company owners of 43.294 million yuan, all of which turned losses into profits over the previous year. Overall gross margin increased from 14.4% in the same period in 2025 to 20.1%, up 5.7 percentage points year on year; net cash outflow from operating activities narrowed from 63.5 million yuan in the same period in 2025 to 26.6 million yuan, and operating cash flow performance further improved.

According to the Zhitong Finance App, Spike Health (00314.HK) announced its 2026 interim results, with total revenue of about 740 million yuan, IFRS net profit of 42.924 million yuan, and profit attributable to parent company owners of 43.294 million yuan, all of which turned losses into profits over the previous year. Overall gross margin increased from 14.4% in the same period in 2025 to 20.1%, up 5.7 percentage points year on year; net cash outflow from operating activities narrowed from 63.5 million yuan in the same period in 2025 to 26.6 million yuan, and operating cash flow performance further improved.